Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5430-5435
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5430
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5430
Figure 5 Sum score of question 2 and question 3 in the GSRS score.
Data are expressed as means ± SE. VAS scores in the lafutidine group were significantly worse than in the lansoprazole group (P = 0.0068, ANOVA for repeated measures). VAS: Visual analog scale.
- Citation: Takenaka R, Okada H, Kawano S, Komazawa Y, Yoshinaga F, Nagata S, Inoue M, Komatsu H, Onogawa S, Kushiyama Y, Mukai S, Todo H, Okanobu H, Manabe N, Tanaka S, Haruma K, Kinoshita Y. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease. World J Gastroenterol 2016; 22(23): 5430-5435
- URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5430.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5430